Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Herpes zoster following COVID-19: a report of three cases.

Literature DB >> 33262097

Herpes zoster following COVID-19: a report of three cases.

Lucia Brambilla¹, Carlo Alberto Maronese¹, Athanasia Tourlaki¹, Stefano Veraldi¹.

Abstract

Entities: Chemical Disease Species

Year: 2020 PMID： 33262097 DOI： 10.1684/ejd.2020.3924

Source DB: PubMed Journal: Eur J Dermatol ISSN： 1167-1122 Impact factor: 3.328

× No keyword cloud information.

11 in total

1. Hyperactivated Mast Cells Pathogenesis Hypothesis for COVID-19 Cutaneous Manifestations.

Authors: Darrell O Ricke
Journal: JID Innov Date: 2021-08-23

2. An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers.

Authors: Alpana Mohta; Achala Mohta; Radhe Shyam Nai; Aakanksha Arora; Suresh Kumar Jain; Alok Mohta; Rajesh Dutt Mehta; Bhikam Chand Ghiya; Vijeta Prasad; Rajesh Khokhar; Rajat Toteja; Gaurav Bha Rgava
Journal: Indian Dermatol Online J Date: 2021-09-10

3. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus.

Authors: M D Maldonado; J Romero-Aibar
Journal: Brain Behav Immun Health Date: 2021-10-30

4. Increased Risk of Herpes Zoster in Adults ≥50 Years Old Diagnosed With COVID-19 in the United States.

Authors: Amit Bhavsar; Germain Lonnet; Chengbin Wang; Konstantina Chatzikonstantinidou; Raunak Parikh; Yves Brabant; Nathalie Servotte; Meng Shi; Robyn Widenmaier; Emmanuel Aris
Journal: Open Forum Infect Dis Date: 2022-03-09 Impact factor: 3.835

5. Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report.

Authors: Colm Kerr; Susan O'Neill; Anna Szucs; Oliver Darmody; Claire Williamson; Ciaran Bannan; Concepta Merry
Journal: IDCases Date: 2022-02-12

Herpes zoster following COVID-19: a report of three cases.

1. Hyperactivated Mast Cells Pathogenesis Hypothesis for COVID-19 Cutaneous Manifestations.

2. An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers.

3. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus.

4. Increased Risk of Herpes Zoster in Adults ≥50 Years Old Diagnosed With COVID-19 in the United States.

5. Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report.

6. Case of atypical disseminated herpes zoster in a patient with COVID-19: A diagnostic challenge in COVID era.

7. Herpes zoster duplex following COVID-19.

Review 8. Characteristics of herpes zoster infection in patients with COVID-19: a systematic scoping review.

9. COVID-19 Vaccination in Patients with Classic Kaposi's Sarcoma.

10. Pityriasis rosea and COVID-19.